Characteristic | G + S (n = 100) | G-A (n = 114) | P-value |
---|---|---|---|
Age, years | 0.836 | ||
≤ 55 | 32 (32) | 38 (33) | |
> 55 | 68 (68) | 76 (67) | |
Sex | 0.190 | ||
Men | 82 (82) | 85 (75) | |
Women | 18 (18) | 29 (25) | |
Tumor size, cm | 0.393 | ||
≤ 4 | 23 (23) | 27 (24) | |
5 to 6 | 26 (26) | 21 (18) | |
> 6 | 51 (51) | 66 (58) | |
Pathological tumor stage | 0.600 | ||
T1 | 5 (9) | 8 (9) | |
T2 | 28 (49) | 45 (53) | |
T3 | 16 (28) | 26 (31) | |
T4 | 8 (14) | 6 (7) | |
Pathological nodal stage | 0.153 | ||
N0 | 10 (15) | 24 (28) | |
N1 | 20 (31) | 29 (34) | |
N2 | 23 (35) | 23 (27) | |
N3 | 12 (19) | 9 (11) | |
TNM stage | 0.355 | ||
IA | 2 (2) | 5 (4) | |
IB | 19 (19) | 23 (20) | |
II | 18 (18) | 30 (26) | |
IIIA | 29 (29) | 31 (27) | |
IIIB | 14 (14) | 14 (12) | |
IV | 18 (18) | 11 (10) | |
Gross type (Borrman) | 0.154 | ||
I | 3 (3) | 2 (2) | |
II | 20 (20) | 12 (11) | |
III | 59 (60) | 66 (61) | |
IV | 17 (17) | 29 (27) | |
Type of gastrectomy | 0.958 | ||
Total | 60 (60) | 68 (60) | |
Sub-total | 40 (40) | 46 (40) | |
Complications | 24 (24) | 11 (10) | 0.005c |
Adjunctive therapy | 12 (12) | 14 (12) | 0.903 |